Orchestra BioMed Holdings, Inc. (OBIO)
NASDAQ: OBIO · Real-Time Price · USD
5.28
+0.11 (2.13%)
Nov 20, 2024, 4:00 PM EST - Market closed
Orchestra BioMed Holdings Market Cap
Orchestra BioMed Holdings has a market cap or net worth of $200.71 million as of November 21, 2024. Its market cap has increased by 3.03% in one year.
Market Cap
200.71M
Enterprise Value
135.62M
1-Year Change
3.03%
Ranking
Category
Stock Price
$5.28
Market Cap Chart
Since August 4, 2020, Orchestra BioMed Holdings's market cap has increased from $197.44M to $200.71M, an increase of 1.66%. That is a compound annual growth rate of 0.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 200.71M | -38.50% |
| Dec 29, 2023 | 326.34M | 191.65% |
| Dec 30, 2022 | 111.90M | -45.72% |
| Dec 31, 2021 | 206.14M | -21.31% |
| Dec 31, 2020 | 261.96M | 32.68% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corbus Pharmaceuticals Holdings | 201.69M |
| Enanta Pharmaceuticals | 199.60M |
| ADC Therapeutics | 199.18M |
| Lexeo Therapeutics | 199.06M |
| Acrivon Therapeutics | 198.65M |
| Compass Therapeutics | 195.38M |
| Profound Medical | 194.34M |
| InfuSystem Holdings | 193.50M |